↓ Skip to main content

PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes

Overview of attention for article published in Frontiers in oncology, July 2021
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PGK1 Is a Key Target for Anti-Glycolytic Therapy of Ovarian Cancer: Based on the Comprehensive Analysis of Glycolysis-Related Genes
Published in
Frontiers in oncology, July 2021
DOI 10.3389/fonc.2021.682461
Pubmed ID
Authors

Rui Gou, Yuexin Hu, Ouxuan Liu, Hui Dong, Lingling Gao, Shuang Wang, Mingjun Zheng, Xiao Li, Bei Lin

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 19%
Researcher 3 14%
Student > Ph. D. Student 2 10%
Student > Doctoral Student 1 5%
Student > Bachelor 1 5%
Other 4 19%
Unknown 6 29%
Readers by discipline Count As %
Unspecified 4 19%
Biochemistry, Genetics and Molecular Biology 4 19%
Medicine and Dentistry 2 10%
Agricultural and Biological Sciences 1 5%
Nursing and Health Professions 1 5%
Other 2 10%
Unknown 7 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 May 2022.
All research outputs
#23,011,330
of 25,655,374 outputs
Outputs from Frontiers in oncology
#16,227
of 22,758 outputs
Outputs of similar age
#389,945
of 455,354 outputs
Outputs of similar age from Frontiers in oncology
#865
of 1,420 outputs
Altmetric has tracked 25,655,374 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,758 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 455,354 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,420 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.